Treatment of extra conjunctival growth through ayurvedic line of management

A placebo control clinical study to evaluate the effect of pippalyadi anjana in prevention of recurrence of arma (pterygium) following arma chedana - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054638

Enrollment

Registered

2023-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H110- Pterygium of eye Health Condition 2: H110- Pterygium of eye Health Condition 3: H110- Pterygium of eye

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients having either any one of the clinical features of Chedana sadya arma such as Charmabha Bahala Snayu Mamsaghanaavrutta Krushnamandalaga. Controlled Diabetic and Controlled Hypertensive. Patients willing to come for follow for 6 Months

Exclusion criteria

Exclusion criteria: Lekhana Sadya Arma. Pseudo Pterygium. Recurred Pterygium. Patients having any inflammatory diseases of the eye. Patients suffering from any of the systemic disorders. Pregnant women and lactating mothers

Design outcomes

Primary

Measure	Time frame
to prevent the recurrence of pterygiumTimepoint: 220 days	—

Secondary

Measure	Time frame
reduction in the redness foreign body sensation & watering of eyeTimepoint: 40 days	—

Countries

India

Contacts

Public ContactDr Veerayya R Hiremath

Shree jagadguru gavisiddeshwara ayurvedic medical college

drvrh.aug15@gmail.com9448544376

Outcome results